Mytos

Mytos (mytos.bio): 3 changes recorded in its website history since July 2021. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

HeadlineBetween 14 May 2026 and 6 November 2026
BeforeScaling Regenerative Medicine to Millions of Patients
AfterTissue manufacturing unlocked. Commercially viable scale with automated manufacturing.
Observed on the company’s website; business claims are not independently verified.
earlier archived page current websiteHistorical capture not publicly availableLink to observation
HeadlineBetween 16 January 2025 and 15 August 2025
BeforeInfrastructure for Cell Manufacturing
AfterScaling Regenerative Medicine to Millions of Patients
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
HeadlineBetween 19 January 2022 and 10 August 2022
BeforeIncrease the speed and quality of your team's research with automated cell culture.
AfterInfrastructure for Cell Manufacturing
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation

First recorded website

Observed 29 July 2021

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Increase the speed and quality of your team's research with automated cell culture.

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

Seen November 2026 · 1 capture · latest observed messagingTissue manufacturing unlocked. Commercially viable scale with automated manufacturing.
Automated CDMO for Regenerative Medicines + Developer of iDEM automated tissue production systems. Scale to thousands of patients in months, at 40% lower cost. iDEM technology, UK facility.
This wording observed 6 November 2026.
current websiteHistorical capture not publicly available
August 2025 – May 2026 · 2 capturesScaling Regenerative Medicine to Millions of Patients
Scaling Regenerative Medicine to Millions of Patients. Mytos's Automated Regenerative Medicine CDMO, powered by IDEM, delivers unmatched speed, scale, and efficiency.
This wording observed 14 May 2026.
archived page
Inspect 2 captures in this group
- 15 August 2025 · Scaling Regenerative Medicine to Millions of Patients archived page
- 14 May 2026 · Scaling Regenerative Medicine to Millions of Patients archived page
August 2022 – January 2025 · 5 capturesInfrastructure for Cell Manufacturing
The Infrastructure for Cell Manufacturing
This wording observed 16 January 2025.
archived page
Inspect 5 captures in this group
- 10 August 2022 · Infrastructure for Cell Manufacturing archived page
- 30 November 2023 · Infrastructure for Cell Manufacturing archived page
- 17 January 2024 · Infrastructure for Cell Manufacturing archived page
- 12 August 2024 · Infrastructure for Cell Manufacturing archived page
- 16 January 2025 · Infrastructure for Cell Manufacturing archived page
July 2021 – January 2022 · 2 capturesIncrease the speed and quality of your team's research with automated cell culture.
This wording observed 19 January 2022.
archived page
Inspect 2 captures in this group
- 29 July 2021 · Increase the speed and quality of your team's research with automated cell culture. archived page
- 19 January 2022 · Increase the speed and quality of your team's research with automated cell culture. archived page

Cite this record

StartupHistory, “Mytos” company record, https://startuphistory.org/c/mytos.bio

Machine-readable: /c/mytos.bio.json. How changes are found: method.